Pulmonary endarterectomy service
Papworth Hospital is the only centre in the UK offering this surgery and has performed over 1200 operations since 1996. Pulmonary endarterectomy (PEA, also known as PTE) is a surgical operation in which the blood vessels of the lungs are cleared of clot and scar material. In a large proportion of patients who undergo this operation, their level of activity, quality of life and life expectancy are significantly improved and pulmonary endarterectomy surgery can be thought of as a cure for most patients.
CTEPH is a form of pulmonary hypertension that occurs as the result of blood clots blocking off the arteries of the lungs. Whilst most of these blood clots originate in the veins, many people with this condition may be unaware that these clots are forming. Over time, the blood clots build up in the blood vessels of the lungs which become permanently scarred with narrowing and decreased blood flow. This results over time in increased pressure and resistance to blood flow in the lungs leading to pulmonary hypertension and right heart failure. When severe, this situation leads to increasing breathlessness, exercise limitation and reduced life expectancy.
PEA is a surgical operation in which the blood vessels of the lungs are cleared of clot and scar material and usually takes 8-10 hours. The patient is attached to a heart-lung bypass machine prior to their body temperature being cooled to 20 °C which reduces the body’s oxygen requirement and provides protection to organs of the body during the surgery. During the critical part of the surgery where the clots and scarring are removed the heart-lung bypass machine is turned off for up to 20 minutes to create a bloodless field. The bypass machine is then turned back on to re-perfuse the body’s organs again before it is turned off to remove the clots and scarring from the other lung. Research led by the Papworth PEA Team has shown that this is safest way to perform this operation.
Although the operation sounds simple, it is actually technically very difficult to get access to the arteries of the lungs, and the procedure itself is a major undertaking. For this reason it is necessary to ensure that patients who might potentially benefit from this operation are thoroughly evaluated. Not everyone with CTEPH will be suitable for this operation, and a number of additional investigations must be performed in order to assess the appropriateness of surgery and the level of risk involved. However in a large proportion of patients who undergo this operation, their level of activity, quality of life and life expectancy are significantly improved and pulmonary endarterectomy surgery can be thought of as a cure for most patients.
Prior to being accepted for surgery, you will have the opportunity to discuss the operation in detail with the surgeon and other members of the team at Papworth Hospital. Should you or your family have any questions or concerns they will be happy to address them prior to any decisions being made. A copy of the patient’s guide and agreement to consent information booklet is available here.
The majority of patients (70-80%) referred to our service will benefit from surgery. Occasionally the type of disease may not be appropriate for surgery, or the patient may be too well or unwell to undergo the operation. In this circumstance you will be followed carefully and there may be some medical treatments available that can help improve the severity of pulmonary hypertension. At present, Papworth Hospital is working closely with other centres around the world to develop more effective treatments for this condition.
If you would like further information regarding CTEPH or pulmonary endarterectomy (PE) please email our PE Specialist Nurses email@example.com
- Pulmonary hypertension service
- Contacts and useful links
- The staff
- Information for patients
- For healthcare professionals
- Pulmonary endarterectomy